Safety of umbilical cord blood-derived mesenchymal stem cells (MSCs) following 5-azaserine induction and inhibition of human cardiac myocyte apoptosis by MSCs

Saudi Medical Journal

Volumn 30, Issue 9, 2009, Pages 1144-1149

  Huang, Jing Ling ^a   Yang, Shui Xiang ^b  

^a LANZHOU UNIVERSITY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AZASERINE; BETA ACTIN; CYCLIN A; CYCLIN DEPENDENT KINASE 2; PROTEIN C FOS; PROTEIN P53; TELOMERASE; TELOMERASE REVERSE TRANSCRIPTASE;

APOPTOSIS; ARTICLE; CARCINOGENESIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DELIVERY; DONOR; ENZYME ACTIVITY; HEART MUSCLE CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; KARYOTYPE; MESENCHYMAL STEM CELL; NUDE MOUSE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SAFETY; UMBILICAL CORD BLOOD;

ANIMALS; APOPTOSIS; AZASERINE; FETAL BLOOD; HUMANS; KARYOTYPING; MESENCHYMAL STEM CELLS; MICE; MICE, NUDE; MYOCARDIUM;

EID: 70449704144     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Sensebé L, Bourin P. Mesenchymal stem cells for therapeutic purposes. Transplantation 2009; 87 (9 Suppl): S49-S53.
2. Menicanin D, Bartold PM, Zannettino AC, Gronthos S. Genomic profiling of mesenchymal stem cells. Stem Cell Rev Rep 2009; 5: 36-50.
3. Huang GP, Pan ZJ, Jia BB, Zheng Q, Xie CG, Gu JH, et al. Ex vivo expansion and transplantation of hematopoietic stem/progenitor cells supported by mesenchymal stem cells from human umbilical cord blood. Cell Transplant 2007; 16: 579-585.
4. Martins AA, Paiva A, Morgado JM, Gomes A, Pais ML. Quantification and immunophenotypic characterization of bone marrow and umbilical cord blood mesenchymal stem cells by multicolor flow cytometry. Transplant Proc 2009; 41: 943-946.
5. Sordi V. Mesenchymal stem cell homing capacity. Transplantation 2009; 87 (9 Suppl): S42-S45.
6. Karp JM, Leng Teo GS. Mesenchymal stem cell homing: the devil is in the details. Cell Stem Cell 2009; 4: 206-216.
7. Dimitriou H, Perdikogianni Ch, Martimianaki G, Choumerianou DM, Pelagiadis J, Kalmanti M. Are mesenchymal stromal cells from children resistant to apoptosis? Cell Prolif 2009; 42: 276-283.
8. Schwartz LM, Gao Z, Brown C, Parelkar SS, Glenn H. Cell death in myoblasts and muscles. Methods Mol Biol 2009; 559: 313-332.
9. Walther G, Gekas J, Bertrand OF. Amniotic stem cells for cellular cardiomyoplasty: promises and premises. Catheter Cardiovasc Interv 2009; 73: 917-924.
10. Derval N, Barandon L, Dufourcq P, Leroux L, Lamazière JM, Daret D, et al.Epicardial deposition of endothelial progenitor and mesenchymal stem cells in a coated muscle patch after myocardial infarction in a murine model. Eur J Cardiothorac Surg 2008; 34: 248-254.
11. Chiu RC. MSC immune tolerance in cellular cardiomyoplasty. Semin Thorac Cardiovasc Surg 2008; 20: 115-118.
12. Wagner W, Bork S, Horn P, Krunic D, Walenda T, Diehlmann A, et al. Aging and replicative senescence have related effects on human stem and progenitor cells. PLoS One 2009; 4: e5846.
13. Riekstina U, Muceniece R, Cakstina I, Muiznieks I, Ancans J. Characterization of human skin-derived mesenchymal stem cell proliferation rate in different growth conditions. Cytotechnology 2008; 58: 153-162.
14. Huang JL, Yang SX. Differentiation of mesenchymal stem cells derived from human umbilical cord into cardiomyocytes. Journal of Clinical Rehabilitative Tissue Engineering Research , 2008; 12: 9367-9370
15. Stolzing A, Jones E, McGonagle D, Scutt A. Age-related changes in human bone marrow-derived mesenchymal stem cells: consequences for cell therapies. Mech Ageing Dev 2008; 129: 163-173.
16. Tokalov SV, Gruener S, Schindler S, Iagunov AS, Baumann M, Abolmaali ND. A number of bone marrow mesenchymal stem cells but neither phenotype nor differentiation capacities changes with age of rats. Mol Cells 2007; 24: 255-260. (Pubitemid 350177186)
17. Wei LL, Gao K, Liu PQ, Lu XF, Li SF, Cheng JQ, et al. Mesenchymal stem cells from Chinese Guizhou minipig by hTERT gene transfection. Transplant Proc 2008; 40: 547-550.
18. Cragg MS, Harris C, Strasser A, Scott CL. Unleashing the power of inhibitors of oncogenic kinases through BH3 mimetics. Nat Rev Cancer 2009; 9: 321-326.
19. Zhang ZX, Guan LX, Zhang K, Wang S, Cao PC, Wang YH, et al. Cytogenetic analysis of human bone marrow-derived mesenchymal stem cells passaged in vitro. Cell Biol Int 2007; 31: 645-648. (Pubitemid 46660640)
20. Yang SX, Xu J, Xu GY, Dai HY, Tian JH. Autologous bone marrow stem cell transplantation for treating myocardial infarction in 6 cases A 4 years follow-up. Journal of Clinical Rehabilitative Tissue Engineering Research 2009; 10: 1969-1972.
21. Block GJ, Ohkouchi S, Fung F, Frenkel J, Gregory C, Pochampally R, etc. Multipotent stromal cells are activated to reduce apoptosis in part by upregulation and secretion of stanniocalcin-1. Stem Cells 2009; 27: 670-681.
22. Nakanishi C, Yamagishi M, Yamahara K, Hagino I, Mori H, Sawa Y, et al. Activation of cardiac progenitor cells through paracrine effects of mesenchymal stem cells. Biochem Biophys Res Commun 2008; 374: 11-16.
23. Markel TA, Crisostomo PR, Wang M, Wang Y, Lahm T, Novotny NM, et al. TNFR1 signaling resistance associated with female stem cell cytokine production is independent of TNFR2-mediated pathways. Am J Physiol Regul Integr Comp Physiol 2008; 295: R1124-R1130.
24. Nagaya N, Kitamura S. [Regenerative medicine for heart failure]. Nippon Rinsho 2008; 66: 978-983. Japanese.